Y
Yi Li
Researcher at Erasmus University Rotterdam
Publications - 7
Citations - 179
Yi Li is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Transplantation & Calcineurin. The author has an hindex of 6, co-authored 7 publications receiving 145 citations. Previous affiliations of Yi Li include Sichuan University.
Papers
More filters
Journal ArticleDOI
Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients
Louise M. Andrews,Yi Li,Brenda C. M. de Winter,Yunying Shi,Carla C. Baan,Teun van Gelder,Dennis A. Hesselink +6 more
TL;DR: Traditional TDM, perhaps following pre-emptive genotyping for Tac-metabolizing enzymes, must suffice for a few years before these strategies can be implemented in clinical practice.
Journal ArticleDOI
Association between promoter variants of interleukin-18 and schizophrenia in a Han Chinese population.
TL;DR: IL-18 gene promoter polymorphisms may not contribute to the susceptibility of schizophrenia in a Han Chinese population, but two single-nucleotide polymorphisms, -137 G/C and -607 C/A, may play a role in the development of perception disorder and aggressive action, respectively.
Journal ArticleDOI
CNI induced Th17/Treg imbalance and susceptibility to renal dysfunction in renal transplantation
TL;DR: It is indicated that CNI was associated with Th17/Treg imbalance in peripheral blood, which supported the followed generation of renal dysfunction after transplantation.
Journal ArticleDOI
Inhibition of T Helper Cell Differentiation by Tacrolimus or Sirolimus Results in Reduced B-Cell Activation: Effects on T Follicular Helper Cells.
Rens Kraaijeveld,Yi Li,Lin Yan,Kitty de Leur,Marjolein Dieterich,Annemiek M.A. Peeters,Lanlan Wang,Yunying Shi,Carla C. Baan +8 more
TL;DR: It is found that TAC and SRL inhibited the differentiation of naive T cells into functional Tfh-like cells, a finding that can be extrapolated to immunosuppressive regimens in transplant patients.
Journal ArticleDOI
An overview of T follicular cells in transplantation: spotlight on their clinical significance
Qian Niu,Rens Kraaijeveld,Yi Li,Aleixandra Mendoza Rojas,Yunying Shi,Lanlan Wang,Nicole M. van Besouw,Carla C. Baan +7 more
TL;DR: This new concept in the treatment of the humoral rejection response will improve graft and patient survival after organ transplantation and feed the hypothesis that immunosuppressive drugs targeting the actions of Tfh cells have huge therapeutic potential.